Varun Takkar
Stock & Options Trading, Technical Analysis, Trading Community
Marvell's jump to $290 on its S&P 500 inclusion is a forced institutional pump that looks like a short-term top. Once index funds finish their mechanical rebalancing, that artificial demand dries up and often triggers a sharp sell-the-news flush. The large gap below on the chart acts as a magnet, pointing to a healthy pullback toward the $214-220 zone, where $214 lines up with the 0.786 Fibonacci level. x.comÂ
Marvell's run looks like distribution, not accumulation: it doubled in four months on decelerating earnings, spiked on a CEO's compliment and printed its heaviest volume at the top. After Jensen Huang called it the next trillion-dollar company at Computex, it jumped 32% in a day, capping a 105% gain in 18 weeks on record volume of 441 million shares, while EPS growth slowed four straight quarters from 158% to 29%. A 40% collapse from the peak in five weeks followed, the mark of a climax run. … Show more
Marvell is priced too aggressively, with its valuation not yet reflecting actual capacity. Especially in the late stage of a raging bull market, stocks priced this aggressively are best avoided. x.comÂ
Marvell's S&P 500 inclusion should force passive buying from every index-tracking fund once it takes effect, with the action starting Monday. A brief pullback is likely before the next leg up toward a $1 trillion market cap. x.com x.comÂ
Marvell falling on a strong quarter and guidance usually means all the good news is already priced in. x.comÂ
Marvell's risk/reward is no longer favorable after the stock ran three to four times from the $70s in March, when it was the most obviously undervalued chip stock. Jensen Huang's call for a $1T company is partly driven by his dislike of Broadcom's Hock Tan, and the Celestial AI angle is overhyped relative to the value it adds. A bounce is likely from here, but there is no case for adding exposure at the current price. x.com x.com x.comÂ
A Lumentum deal would put Marvell in a much better competitive position, making its shares an obvious buy here, especially for existing Lumentum shareholders. If the deal breaks, Marvell shares would jump sharply; a moderate premium could mean near-term weakness or sideways trading but would be a great long-term deal. A big premium could push shares down further, though much of that risk is already priced in. x.com x.comÂ
Marvell's ambitious long-range outlook is encouraging about hyperscaler and AI-lab spending plans, but hitting it depends on AI revenue and token consumption soaring through decade's end. Even if its FY28 estimates rise again, Marvell trades at a healthy premium to Nvidia and Broadcom, especially on a GAAP basis, and those two are growing fast too. x.comÂ
Marvell is a loser from the AI-lab slowdown, because it can't earn premium margins if Nvidia and Broadcom also see a pause. Lab leaders including Elon Musk, Dario Amodei and Sam Altman have pivoted to warning that AI could kill you, which, with AI already polling badly, will make it much harder for AI to attract investment. x.comÂ
Marvell is a steal at roughly 45x forward free cash flow for a business growing 50%, with a $440 price target by late 2027. It has raised its fiscal 2028 revenue growth outlook to 50%, with roughly $18 billion of revenue now in sight and a credible, clear path to about $5 billion of free cash flow, even though the stock is down more than 25% since June. x.comÂ
Marvell is expensive, growing more slowly and not founder-led, so owning it directly makes little sense. x.comÂ
